Bolt Threads, a pioneer in sustainable biomaterials for consumer products, today reported the closing of its previously announced business combination with Golden Arrow Merger Corp (Golden Arrow). GAMC shareholders approved the transaction at GAMC’s special meeting held on August 9, 2024.

“We are pleased to begin our next chapter in the public market as the leading biomaterials platform, focused on transforming the high-volume consumer goods industries by delivering superior alternative materials tapped from nature,” said Dan Widmaier, Bolt Threads co-founder and chief executive officer. “We are thankful to our leadership team, employees and partners for their support on our journey. We believe Bolt Threads is well-positioned to capitalize on significant growth opportunities and generate substantial value for all stakeholders.”

“Bolt Threads’ biomaterials platform offers a complete solution of sustainable alternatives from nature that can transform a multitude of high-volume consumer goods with biodegradable, non-toxic alternatives,” said Jacob W. Doft, Chairman of the Board at Golden Arrow. “We look forward to accelerating Bolt Threads’ growth and solidifying a long-term partnership.”

BTIG, LLC acted as financial advisor and Latham & Watkins LLP acted as legal advisor to Bolt Threads. Greenberg Traurig, LLP acted as legal advisor to Golden Arrow. Ellenoff Grossman & Schole LLP acted as legal advisor to BTIG, LLC.